Unknown Author
January 23, 2026
Kirkland Represents General Catalyst on $670 Million Close of Health Assurance Fund II

1 min
AI-made summary
- Kirkland & Ellis advised General Catalyst Group Management, LLC on the closing of its second Health Assurance Fund, which raised $670 million
- The Health Assurance Fund II aims to support investments in companies focused on consumer-centric and data-driven healthcare solutions
- The Kirkland team included partners and associates from investment funds, regulatory solutions, and tax practices, led by Matthew Smith, Jonathan Lipnick, and Matthew Block.
Kirkland & Ellis advised General Catalyst Group Management, LLC (“General Catalyst”), a leading venture capital firm, on the closing of its second heath assurance focused fund (“Health Assurance Fund II”), which raised $670 million. Health Assurance Fund II will enable General Catalyst to continue to invest in innovative companies that are accelerating consumer-centric and data-driven healthcare solutions designed to help people stay well, while bending the cost curve. The Kirkland team was led by investment funds partners Matthew Smith, Jonathan Lipnick and Matthew Block, with involvement from investment funds partner Daniel Lavon-Krein, investment funds regulatory solutions partner Alpa Patel, tax partner Lee Morlock, investment funds associates Charles Chen, Ben Turin, Daniel Sylvia and Thomas Kelley, investment funds regulatory solutions associate Chris Pristouris, and tax associate Steven Cantor.
Article Author
Unknown Author
The Sponsor
